TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT05955391 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05955391
- Sponsor
- Shenzhen TargetRx Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2024-12-29
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.